THE DEAL, AT A GLANCE
From the announcementKasvu Therapeutics
01Who is involvedBacked by Hadean Ventures, leading investors in Finnish science, innovation · Helsinki, a company developing a new generation ofFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedKasvu Therapeutics raised Series A, announced 2026-09-24From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersKasvu Therapeutics’ Series A provides financing to advance a novel TrkB potentiator toward clinical development for neuropsychiatric disorders.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Kasvu Therapeutics · Financing Record
Explore source-linked visual explanations for Kasvu Therapeutics. Unsupported claims are withheld while source review continues.
Record 12923 · Recorded date: 2026-09-24
Explore company records →